Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Telomerase Regulation through Post-translational Modifications of Dyskerin
EF 2014-15
Résumé
The enzyme telomerase is involved in protecting cells from death through genetic stabilization, and is typically present in cancer cells while absent in most normal cells. This makes it a good enzyme to target in anticancer therapy if a better understanding of how it works biochemically can be gained through research. Telomerase is also a potential target for treating premature aging syndromes like dyskeratosis congenita, which are characterized by deficiencies in the enzyme and its interacting proteins. One such interacting protein is dyskerin, which is essential for the stability of telomerase. Very little is known about the regulation of dyskerin and how its regulation or dysregulation can affect telomerase. In the same way that improving knowledge of telomerase will open treatment avenues for cancer and premature aging disorders, a more comprehensive understanding of dyskerin and its regulation is needed to implicate treatment strategies which target this protein.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
331385
Name
MacNeil Deanna
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Telomerase Regulation through Post-translational Modifications of Dyskerin
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Cancer; Dyskeratosis Congenita; Dyskerin; Post-Translational Modification; Rnp Complex Assembly; Sumoylation; Telomerase; Telomerase Rna; Telomeres
Abstract
The enzyme telomerase is involved in protecting cells from death through genetic stabilization, and is typically present in cancer cells while absent in most normal cells. This makes it a good enzyme to target in anticancer therapy if a better understanding of how it works biochemically can be gained through research. Telomerase is also a potential target for treating premature aging syndromes like dyskeratosis congenita, which are characterized by deficiencies in the enzyme and its interacting proteins. One such interacting protein is dyskerin, which is essential for the stability of telomerase. Very little is known about the regulation of dyskerin and how its regulation or dysregulation can affect telomerase. In the same way that improving knowledge of telomerase will open treatment avenues for cancer and premature aging disorders, a more comprehensive understanding of dyskerin and its regulation is needed to implicate treatment strategies which target this protein.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
MacNeil, Deanna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~